
The first company to spin out from Orrick, Herrington & Sutcliffe’s in-house technology lab has been acquired by legal spend management startup Brightflag, the company said on Wednesday.
The purchase marks a milestone for Orrick and spinout Joinder, as well as the first acquisition for Dublin, Ireland-founded Brightflag.
Joinder was co-founded by former Orrick partner Don Keller, who also has served as the company’s CEO.
The software platform started as an internal system built by Orrick Labs, a team of technologists, for some of the firm’s clients. Joinder then split off as an independent business that aims to assist corporate legal departments with activities like task and document management.
Joinder’s product will be integrated with Brightflag’s. Brightflag also markets its platform to in-house lawyers, including tools for matter management and legal spend management.
The company said it has raised $39.1 million in total funding from investors since its 2014 founding. Financial terms of the Joinder acquisition were not disclosed Wednesday.
Brightflag’s customers include Syngenta Group, SAP and MongoDB Inc, according to the company.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas